TraDIS-Xpress finds mechanisms of action and synergies of a novel lipid IVA biosynthesis inhibitor
Ontology highlight
ABSTRACT: We used TraDIS-Xpress to determine the mechanism of action of a novel antimicrobial compound. We found that it inhibits lipid IVA biosynthesis in both Escherichia coli and Salmonella enterica serovar Typhimurium. We also were able to determine mechanisms of synergy with colistin, through ATP biosynthesis and the BasSR signalling system.
INSTRUMENT(S): NextSeq 500
ORGANISM(S): Salmonella enterica subsp. enterica serovar Typhimurium
SUBMITTER: emma holden
PROVIDER: E-MTAB-13250 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA